NaV1.7 as a Pharmacogenomic Target for Pain: Moving Toward Precision Medicine.
Trends Pharmacol Sci
; 39(3): 258-275, 2018 03.
Article
in En
| MEDLINE
| ID: mdl-29370938
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pain
/
Pharmacogenetics
/
Precision Medicine
/
Molecular Targeted Therapy
/
NAV1.7 Voltage-Gated Sodium Channel
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Trends Pharmacol Sci
Year:
2018
Document type:
Article